Evidence map›Paper›PMID 24080454›Full record

ArticleSleep medicine reviews2014

Leptin: a biomarker for sleep disorders?

Weihong Pan, Abba J Kastin

Open access · greenAbstract read
In one paragraph

Article in Sleep medicine reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Nocturia and obstructive sleep apnoea.Nature reviews. Urology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Weihong PanPennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA. Electronic address: weihong.pan@pbrc.edu.
Abba J KastinPennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA.
Pennington Biomedical Research Center · US

Funding

Leptin Transport Across the BBB: The Role of ObR (+) AstrocytesR01DK054880 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI KASTIN, ABBA J · 1999 to 2014
$4.4M
Neuroimmune modulation across the BBB: Regulation of ILS trafficking by TNFR01NS062291 · NINDS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI PAN, WEIHONG · 2008 to 2012
$1.6M
Consequences of Astrocytic Leptin Receptor Upregulation on ObesityR01DK092245 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI KASTIN, ABBA J · 2011 to 2014
$1.3M
Leptin Transport across the BBB: The Role of ObR (+) astrocytesR56DK054880 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI KASTIN, ABBA J · 2010 to 2010
$222k
NIDDK NIH HHS DK54880NIDDK NIH HHS DK92245NIDDK NIH HHS R01 DK054880NIDDK NIH HHS R01 DK092245NIDDK NIH HHS R56 DK054880NINDS NIH HHS R01 NS062291
6 · The paper itself

Abstract

Leptin, a pleiotropic protein hormone produced mainly by fat cells, regulates metabolic activity and many other physiological functions. The intrinsic circadian rhythm of blood leptin is modulated by gender, development, feeding, fasting, sleep, obesity, and endocrine disorders. Hyperleptinemia is implicated in leptin resistance. To determine the specificity and sensitivity of leptin concentrations in sleep disorders, we summarize here the alterations of leptin in four conditions in animal and human studies: short duration of sleep, sleep fragmentation, obstructive sleep apnea (OSA), and after use of continuous positive airway pressure (CPAP) to treat OSA. The presence and causes of contradictory findings are discussed. Though sustained insufficient sleep lowers fasting blood leptin and therefore probably contributes to increased appetite, obesity and OSA independently result in hyperleptinemia. Successful treatment of OSA by CPAP is predicted to decrease hyperleptinemia, making leptin an ancillary biomarker for treatment efficacy. Current controversies also call for translational studies to determine how sleep disorders regulate leptin homeostasis and how the information can be used to improve sleep treatment.

Indexed as

AppetiteBiomarkersContinuous Positive Airway PressureHumansLeptinObesitySleep Apnea, ObstructiveSleep DeprivationSleep Wake DisordersTreatment OutcomeBiomarkersLeptinCircadian rhythmContinuous positive airway pressureLeptinObstructive sleep apneaSleep durationSleep fragmentation

Identifiers

PMID24080454
PMCPMC4131947
OpenAlexW2094615493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.